Latest News
-
Thursday - March 14, 2013
Improvement of soybean breeding and variety development:
Bayer CropScience Expands Research and Development Cooperation with Nature Source Genetics » more
-
Monday - March 11, 2013
Film former from Bayer MaterialScience proves effective in water resistant sunscreens
Very good skin feel despite sun protection factor 50 » more
-
Friday - March 8, 2013
Not intended for U.S. and UK Media
New Pivotal Phase III Study Initiated with Bayer’s Xarelto® (Rivaroxaban) in Patients with Chronic Heart Failure and Significant Coronary Artery Disease
Low-dose rivaroxaban given fast track designation by U.S. FDA as first novel oral anticoagulant to be evaluated in this high-risk patient group » more
-
Friday - March 8, 2013
Not intended for U.S. and UK Media
Bayer Initiates Xarelto® (Rivaroxaban) Study in Patients with Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention with Stent Placement » more
-
Thursday - March 7, 2013
New waterborne binders from Bayer MaterialScience provide greater freedom for coatings
Aesthetics and comfort in automotive interiors » more
-
Thursday - March 7, 2013
New binder for solvent-free and two-component coatings
Bayer MaterialScience improves chemical resistance of wood coatings » more
-
Thursday - March 7, 2013
Not intended for U.S. and UK Media
Bayer to collaborate with the Children’s Hospital & Research Center Oakland to fight rare blood diseases
Focus on sickle cell anemia / Bayer’s Mission Bay-based scientists to join one of the largest sickle cell programs in the U.S. » more
-
Wednesday - March 6, 2013
Successful year 2012 as a foundation for further growth:
Bayer CropScience gives positive outlook for Latin America after strong growth in 2012
Sales in Brazil and Argentina grow 20 percent in 2012 / Company announces new collaborations and acquisitions in soybeans and wheat » more
-
Wednesday - March 6, 2013
New low-viscosity resin for floor coating and corrosion protection
Solvent-free polyaspartic coatings with high durability
Binder allows simple application without long downtimes » more
-
Wednesday - March 6, 2013
Wide range of binders for primers, adhesives, knifing fillers and topcoats
Bayer MaterialScience offers extensive expertise in raw materials for floor coverings » more
-
Wednesday - March 6, 2013
“Intelligent” coatings protect high-value products
Bayer MaterialScience develops polyurethane dispersions for peel-off and self-healing coatings » more
-
Tuesday - March 5, 2013
Not intended UK Media
Bayer HealthCare Enters into Distribution Agreement to Expand Markets for the Medrad™ Intego™ PET Infusion System » more
-
Tuesday - March 5, 2013
Not intended for U.S. and UK Media: Acute Coronary Syndrome (ACS):
U.S. FDA Issues Complete Response Letter for Bayer’s Xarelto® (Rivaroxaban) for the Reduction of Cardiovascular Events in Patients with ACS » more
-
Monday - March 4, 2013
Bayer CropScience expands cooperation with Brazilian wheat-breeding company Biotrigo » more
-
Monday - March 4, 2013
Not intended for U.S. and UK Media - Long-term extension study of Riociguat in patients with CTEPH:
Interim results from CHEST-2 study support benefits of Bayer’s Riociguat as demonstrated in Phase III CHEST-1 study
Riociguat showed significant and sustained improvements in six minute walking distance (6MWD) and WHO functional class (FC) in patients with inoperable or residual chronic thromboembolic pulmonary hypertension (CTEPH) (1) / Riociguat showed good long-term safety profile (1) » more
-
Friday - March 1, 2013
New mode of action for effective soybean weed control:
Bayer CropScience and Syngenta submit herbicide-tolerance soybean trait for approval in various countries
Launch expected between 2015 and 2020 / New tool to prevent and manage weed resistance » more
-
Friday - March 1, 2013
New polyacrylate binder
Eco-friendly paint for buses, trains and commercial vehicles
Flying sky high in an airship to celebrate Bayer anniversary » more
-
Friday - March 1, 2013
New Bayer MaterialScience competence center steers global developments for wind power stations
Focus on efficient manufacture of rotor blades with polyurethane infusion resin » more
-
Friday - March 1, 2013
Not intended for U.S. and UK Media - 62nd American College of Cardiology (ACC) Annual Scientific Session and Exposition:
New Data on Bayer’s Rivaroxaban Underscores Clinical Benefits of Arterial Clot Prevention in Two Major Cardiovascular Disorders
Benefits of rivaroxaban in acute coronary syndrome (ACS) highlighted in new subanalyses to be presented from Phase III ATLAS ACS 2-TIMI 51 study / Subanalysis from ROCKET AF Phase III trial to be presented, further exploring the protective benefits of rivaroxaban in stroke prevention in patients with AF / Independently, Thrombosis Research Institute (TRI) and Duke Clinical Research Institute to present data from their Registries in patients with AF, which are supported through independent research grants from Bayer and Janssen respectively » more
-
Thursday - February 28, 2013
Financial News Conference
Full Year 2012 Results » more
Copyright @ Bayer AG
Search
Publications
research – The Bayer Scientific Magazine
Stockholders' Newsletter
Annual Report
Sustainable Development Report
Publications Overview
Newsletter
Events
Download Center - Selection
Bayer TV
